Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemizon
United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Chemizon operated as a global drug discovery services company, providing integrated platforms to help convert research discoveries into small molecule therapeutics. The company focused primarily on oncology and infectious diseases, collaborating with academic institutions such as KRIBB to develop novel protein, antibody, and small molecule drugs. There is no evidence of clinical-stage programs or commercialized products; the company's activities were centered around target validation, proteomics, biomarkers, translational medicine research, and stem cell biology in the preclinical stage[5][6][7].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculeProteinAntibody
- Industry
- Drug Discovery Services
02
Partnerships
Korea Research Institute of Bioscience & Biotechnology (KRIBB)
Beyond the preview
Go deeper on Chemizon.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chemizon.